Corteva Q3 2026 Results: Net Loss $570 Million on Revenue of $2.46 Billion
- US stocks
- Earnings
- Materials

Corteva (NYSE: CTVA) reported third quarter 2026 results, with GAAP net sales of $2.46 billion and a GAAP net loss attributable to Corteva of $570.0 million, it said on 12 Nov 2026. Diluted EPS (GAAP) was a loss of $0.85 per share; the company's adjusted pro forma operating EPS, a company-defined measure, was $0.06 per share.
Key highlights
- Revenue (GAAP): $2.46 billion, down 6.1% YoY
- Net loss attributable to Corteva (GAAP): $570.0 million, compared with a loss of $320.0 million a year earlier
- Diluted EPS (GAAP): -$0.85 per share, compared with -$0.47 a year earlier
- Adjusted pro forma operating EPS (company-defined, non-GAAP): $0.06 per share
Summary
| Particulars | Q3 2026 | Q3 2025 | YoY |
|---|---|---|---|
| Revenue | 2,458.0 | 2,618.0 | -6.1% |
| -570.0 | -320.0 | -78.1% | |
| Net income margin | -23.19% | -12.22% | -10.97 pp |
| Diluted EPS ($) | -0.85 | -0.47 | -80.9% |
Figures are in $ million except EPS; YoY compares with Q3 2025. Q3 2026 is the three months to 30 Sep 2026, from the company's release. Earlier quarters are the release's own comparatives, not cross-checked against SEC XBRL data. GAAP; net income attributable to the company; diluted EPS. Changes and margins computed by Blacklitt.
The table shows GAAP figures from the release. Revenue fell 6.1% year on year, to $2.46 billion from $2.62 billion. The net loss attributable to Corteva widened to $570.0 million from $320.0 million, a 78.1% increase in the loss, and the diluted loss per share widened to $0.85 from $0.47.
Net income was -23.2% of revenue this quarter, against -12.2% a year earlier, 11.0 percentage points lower. The year-ago figures are the release's own comparatives and were not cross-checked against SEC XBRL data.
Adjusted figures exclude significant items
The company's adjusted pro forma operating EBITDA, a company-defined non-GAAP measure, was $222 million in the quarter, down 17% from the prior year, with a margin of 14.0%. The release says adjusted measures exclude significant items, separation costs and certain other items, and it reconciles them to GAAP figures on its pages A-4 to A-12.
The release reports pro forma GAAP loss from continuing operations after income taxes of $54 million for the quarter, compared with income of $60 million a year earlier. Its significant items for the quarter were a restructuring and asset related charge of $22 million and a litigation settlement item of $1 million, pre-tax.
Latin America sales fell 31% organically
Organic sales fell 9% for the group. Latin America organic sales declined 31%, and the company attributes this to challenging market dynamics in Brazil, including elevated channel inventory, delayed purchasing, farmer liquidity constraints and high interest rates. North America organic sales rose 7%, and EMEA rose 14%.
Outlook updated for 2026
It now expects adjusted pro forma operating EBITDA of $1.1 billion to $1.125 billion and adjusted pro forma operating EPS of $0.76 to $0.80 per share. It expects net pre-tax restructuring charges of approximately $130 million to $140 million in 2026. The release gives no prior range for these figures.
Inference
For the nine months, the company reported a dividend payment to stockholders of $361.0 million and repurchases of common stock of $500.0 million, and the Board of Directors authorized the first common dividend after the spin. Diluted shares were 667.8 million in the quarter, against 678.7 million a year earlier.
The release does not state the per-share amount or payment dates of the newly authorized dividend, nor a revised figure for any prior period. ET.
Filed with the US SEC on . Reference: Original filing (SEC)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
Figures are from the company's filings with the US Securities and Exchange Commission and are in US dollars. Investing in US stocks from India is subject to the Liberalised Remittance Scheme, currency risk and taxes in both countries.

